Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

Richard Peto, M. C. Pike, P. Armitage et al. · British Journal of Cancer · 1977 · 8.4K citations · Full text

Public Health, Biostatistics, Clinical Medicine +13

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

André M. Murad, Flávia Ferretti Santiago, Andy Petroianu et al. · Cancer · 1993 · 793 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Assessment of response to therapy in advanced breast cancer

J.L. Hayward, Paul P. Carbone, J C Heusen et al. · British Journal of Cancer · 1977 · 706 citations · Full text

Medicine, Oncology, Breast Oncology +10

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.

J. Wils, H. O. Klein, D. J. Th. Wagener et al. · Journal of Clinical Oncology · 1991 · 392 citations · Full text

Medicine, Oncology, Pharmacology +12